Literature DB >> 6871479

Estrogen and progesterone receptor profile patterns in primary breast cancer.

S M Thorpe, C Rose, B V Pedersen, B B Rasmussen.   

Abstract

Estrogen (ER) and progesterone receptor (PgR) analyses have been performed in 884 primary, malignant human breast tumor biopsies. Receptor contents were evaluated with respect to age and menopausal status. The frequency of ER+ tumors was found to be significantly higher in postmenopausal than in pre/perimenopausal women. Age rather than menopausal status was found to be associated with this difference. The significant association with age was found in the post- but not the pre/perimenopausal women. The frequency of PgR+ tumors was found to be significantly lower in the postmenopausal than in the pre/perimenopausal women. Neither age nor menopausal status alone could account for this difference, which appears to be due to a compound effect of the two factors. The distribution of receptor profile patterns is described according to menopausal status. The patterns differ significantly in pre- and postmenopausal women. PgR dominates in the premenopausal tumor while ER dominates in the postmenopausal tumor. This difference is apparent within the subgroup of ER + PgR + patients as well. The current tenets for prediction of recurrent disease utilizing steroid hormone receptor determinations are discussed for the group of ER + PgR + patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871479     DOI: 10.1007/bf01806241

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  19 in total

1.  Scatchard plots: common errors in correction and interpretation.

Authors:  G C Chamness; W L McGuire
Journal:  Steroids       Date:  1975-10       Impact factor: 2.668

2.  Predicting response to endocrine therapy in human breast cancer: a hypothesis.

Authors:  K B Horwitz; W L McGuire
Journal:  Science       Date:  1975-08-29       Impact factor: 47.728

3.  Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors.

Authors:  P M Martin; P H Rolland; J Jacquemier; A M Rolland; M Toga
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

5.  Organisation of the Danish adjuvant trials in breast cancer.

Authors:  K W Andersen; H T Mouridsen; T Castberg; K Fischerman; J Andersen; K Hou-Jensen; H Brincker; H Johansen; E Henriksen; M Rørth; N Rossing
Journal:  Dan Med Bull       Date:  1981-08

6.  Association between steroid hormone receptor status and disease-free interval in breast cancer.

Authors:  J C Allegra; M E Lippman; R Simon; E B Thompson; A Barlock; L Green; K K Huff; H M Do; S C Aitken; R Warren
Journal:  Cancer Treat Rep       Date:  1979-08

7.  Steroid hormone receptors and disease: breast cancer.

Authors:  W L McGuire
Journal:  Proc Soc Exp Biol Med       Date:  1979-10

8.  Analysis of estradiol and progesterone receptors in early and advanced breast tumors.

Authors:  R J King
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  Relationship of presence of progesterone receptors to prognosis in early breast cancer.

Authors:  M F Pichon; C Pallud; M Brunet; E Milgrom
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

10.  Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology.

Authors:  M L Lesser; P P Rosen; R T Senie; K Duthie; C Menendez-Botet; M K Schwartz
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

View more
  4 in total

1.  Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays.

Authors:  S M Thorpe
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

2.  Social and biological factors in relation to survival among black vs. white women with breast cancer.

Authors:  B Valanis; J Wirman; V S Hertzberg
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

Review 3.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

4.  Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies.

Authors:  C M Smyth; D E Benn; T S Reeve
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.